Does modern active surveillance offer an opportunity for new therapeutic strategies in early prostate cancer?
BJU Int
.
2021 Jun;127(6):628-629.
doi: 10.1111/bju.15409.
Epub 2021 Apr 16.
Authors
Vincent J Gnanapragasam
1
2
,
Tristan Barrett
1
3
,
Simon Pacey
1
4
,
Anne Warren
1
5
Affiliations
1
Translational Prostate Cancer Group, CRUK Cambridge Cancer Centre, Cambridge, UK.
2
Division of Urology, Department of Surgery, University of Cambridge, Cambridge, UK.
3
Department of Radiology, University of Cambridge, Cambridge, UK.
4
Department of Oncology, University of Cambridge, Cambridge, UK.
5
Department of Pathology, Addenbrookes Hospital, Cambridge, UK.
PMID:
33774889
DOI:
10.1111/bju.15409
No abstract available
Publication types
Letter
MeSH terms
Humans
Male
Prostatic Neoplasms / therapy*
Watchful Waiting*